However, a pan-cancer study across different epithelial tumor types revealed significant recurrent loss-of-function alterations in CDK7, including recurrent copy-number loss in four epithelial cancer types: ovarian serous, prostate and esophageal carcinoma and cholangiocarcinoma. The gene discussed is CDK7; the disease is cancer.